Valuation: Animalcare Group plc

Capitalization 229M 307M 263M 241M 421M 29.53B 429M 2.88B 1.12B 13.97B 1.15B 1.13B 48.71B P/E ratio 2025
32.5x
P/E ratio 2026 * 65x
Enterprise value 241M 323M 278M 254M 444M 31.12B 452M 3.04B 1.18B 14.72B 1.21B 1.19B 51.32B EV / Sales 2025
1.97x
EV / Sales 2026 * 2.55x
Free-Float
67.4%
Yield 2025
0.93%
Yield 2026 * 1.66%

Last Transcript: Animalcare Group plc

1 day+0.15%
1 month-0.15%
3 months+19.42%
6 months+33.33%
Current year+40.08%
1 week 330
Extreme 330
333
1 month 330
Extreme 330
335
Current year 222
Extreme 222
340
1 year 216
Extreme 216
340
3 years 160
Extreme 160
340
5 years 145
Extreme 145
430
10 years 112
Extreme 112
430
Manager TitleAgeSince
Chief Executive Officer 66 2018-08-02
Director of Finance/CFO 50 2012-06-20
Human Resources Officer - 2010-11-30
Director TitleAgeSince
Director/Board Member 61 2017-07-12
Director/Board Member 66 2022-05-02
Chairman 66 2024-06-19
Change 5d. change 1-year change 3-years change Capi.($)
+0.15%0.00%+31.23%+79.46% 307M
+4.72%+1.37%-52.33%-56.75% 32.58B
+0.35%-8.24%+54.26%+129.08% 9.95B
-1.64%-3.46%+20.97%+47.78% 5.43B
+2.46%+2.46%+15.31%+15.31% 3.37B
-5.00%-6.92%+99.86%+34.18% 2.29B
-0.25%-0.67%-27.04%-8.26% 1.67B
-0.55%-5.89%+42.42%+146.43% 1.39B
+0.47%-4.70%-28.42%-10.16% 1.15B
-1.53%-5.21%+0.57%-45.08% 1.06B
Average -0.42%-3.61%+15.68%+33.20% 5.92B
Weighted average by Cap. +0.54%-1.89%-13.18%-0.36%

Financials

2025 2026 *
Net sales 89.1M 119M 103M 93.82M 164M 11.5B 167M 1.12B 435M 5.44B 448M 438M 18.96B 93.9M 126M 108M 98.87M 173M 12.12B 176M 1.18B 459M 5.73B 472M 462M 19.98B
Net income 2.6M 3.48M 2.99M 2.74M 4.79M 335M 4.87M 32.77M 12.7M 159M 13.07M 12.79M 553M 3.5M 4.69M 4.03M 3.69M 6.44M 452M 6.55M 44.11M 17.1M 214M 17.59M 17.22M 745M
Net Debt 12.3M 16.48M 14.16M 12.95M 22.65M 1.59B 23.03M 155M 60.08M 751M 61.83M 60.52M 2.62B 10.4M 13.93M 11.97M 10.95M 19.15M 1.34B 19.48M 131M 50.8M 635M 52.28M 51.17M 2.21B
Logo Animalcare Group plc
Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. Its principal activity is the development, sale and distribution of licensed veterinary pharmaceuticals to the Companion Animal, Production Animal and Equine veterinary markets. Its segments include Animalcare Europe and Randlab. Animalcare Europe segment is engaged in the development and marketing of pharmaceutical products that provide benefits to animal health across Europe and through the European International Partners network. Randlab segment is engaged in the development, manufacture, and distribution of veterinary pharmaceuticals and nutritional supplements tailored to the equine market. It also provides professional support services to equine veterinarians across Australia, New Zealand, the Middle East, and selected international markets. Its novel products include Plaqtiv+ and Daxocox. Daxocox is a long-acting stand for the treatment of osteoarthritic pain.
Employees
201
Date Price Change Volume
26-05-19 332.00 p +0.15% 12,222
26-05-18 331.50 p -0.15% 45,860
26-05-15 332.00 p +0.15% 230,375
26-05-14 331.50 p 0.00% 84,748
26-05-13 331.50 p -0.15% 287,711
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.315GBP
Average target price
3.360GBP
Spread / Average Target
+1.36%

Annual profits - Rate of surprise